Posts by Benjamin S. Bleier, MD, FACS
-
Acoustic Resonance Therapy Safe and Effective for Nasal Congestion in Rhinitis
Benjamin S. Bleier, MD, FACS, of Mass Eye and Ear, and colleagues found in a two-week randomized trial that acoustic resonance therapy was significantly more effective than sham therapy for moderate or severe nasal congestion secondary to allergic or non-allergic rhinitis, with a response rate of 81% vs. 46%.
-
A Line of Defense Hidden Inside the Nose
Scientists had long tried to understand why colder temperatures correlate with colds, flus and other upper respiratory viruses. The discovery of an innate immune response at the front of the nose has provided a missing link to the phenomenon.
-
Department of Otolaryngology–Head and Neck Surgery Emerges as Global Leader in Early COVID-19 Research
Clinicians and researchers at Mass Eye and Ear rapidly mobilized to conduct studies that combatted the spread of COVID-19 and mitigated its long-term symptoms. Over 25 peer-reviewed articles about the virus were published.
-
Endonasal Surgery Using High-Speed Drill Puts Health Care Team at Risk of COVID-19
High-speed drilling appears to be the single greatest risk factor for potentially infectious aerosolization of new coronavirus during endonasal surgery, even when activated for only several seconds.
Biography
Dr. Benjamin Bleier specializes in sinus, nasal, skull base, and orbital surgery and is committed to providing only the highest quality patient care. As Director of Endoscopic Skull Base Surgery, he focuses on revision and complex sinus surgery as well as state-of-the-art endoscopic management of sinus, orbit, and skull base lesions including sinonasal tumors, cerebrospinal fluid (CSF) leaks, and encephaloceles.
As Co-Director of the Center for Thyroid Eye Disease and Orbital Surgery, he has helped pioneer several new minimally invasive approaches for orbital tumors and has authored more than 175 peer-reviewed articles and book chapters, as well as two textbooks in the field of orbit and sinus-related disease. He lectures both nationally and internationally on topics including the management of orbit and skull base tumors, endoscopic dacyrocystorhinostomy, causes and treatments of sinusitis, and intranasal drug delivery techniques to the brain.
As Director of Otolaryngology Translational Research, Dr. Bleier is an R01 funded surgeon-scientist, holds multiple patents, and has been recognized by the Michael J. Fox Foundation, Boston Magazine, Harvard Medicine Magazine, and The Scientist Magazine for his work.